PMID: 25764676Mar 15, 2015Paper

Chronic hepatitis C virus infection attenuates host antiviral innate immune response

Nihon rinsho. Japanese journal of clinical medicine
Hiroyuki OshiumiTsukasa Seya

Abstract

The innate immune system is essential for controlling viral infection. Hepatitis C virus (HCV) is a causative agent of hepatocellular carcinoma. HCV evades host innate immune response and maintains persistent infection. RIG-I is a cytoplasmic viral RNA sensor and triggers the innate immune response. The Riplet ubiquitin ligase mediates K63-linked polyubiquitination of RIG-I, which is essential for RIG-I activation. Previous studies have shown that HCV NS3-4A protease cleaves RIG-I adaptor MAVS to escape host antiviral response. However, MAVS cleavage is supposed to be not sufficient for viral chronicity. Recently, we found that NS3-4A cleaves both MAVS and Riplet to attenuate RIG-I activation. These findings indicate that HCV NS3-4A cleaves several proteins to shut off antiviral innate immune response.

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.